CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We license and distribute a portfolio of medicines for CNS, critical care and other conditions, both directly and through strategic partnerships, in over 60 countries worldwide. Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.
There is no investment information
No recent news or press coverage available for CNX Therapeutics.